Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells

Journal of Medical Virology

Volumn 75, Issue 3, 2005, Pages 402-411

  Siavoshian, Samila ^a   Abraham, Jean Daniel ^a   Thumann, Christine ^a   Kieny, Marie Paule ^b   Schuster, Catherine ^a  

^a INSERM   (France)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Apoptosis; Hepatitis C virus; P21; P53

Indexed keywords

CORE PROTEIN; DNA FRAGMENT; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN KINASE B; PROTEIN P21; UNCLASSIFIED DRUG; VIRUS CORE PROTEIN NS3; VIRUS CORE PROTEIN NS5A; VIRUS CORE PROTEIN NS5B;

APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HOST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OUTCOMES RESEARCH; PERSISTENT VIRUS INFECTION; PROTEIN EXPRESSION; VIRUS PATHOGENESIS;

APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DENDRITIC CELLS; DNA FRAGMENTATION; HEPACIVIRUS; HUMANS; IMMUNOBLOTTING; PHENOTYPE; PROPIDIUM; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 12944293008     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20283     Document Type: Article

References (65)

1. Auffermann-Gretzinger S, Keeffe EB, Levy S. 2001. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171-3176.
2. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524.
3. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
4. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
5. Behrens SE, Tomei L, De Francesco R. 1996. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 15:12-22.
6. Chartier C, Degryse E, Gantzer M, Dieterlé A, Pavirani A, Mehtali M. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70:4805-4810.
7. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
8. Chung YL, Sheu ML, Yen SH. 2003. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int J Cancer 107:65-73.
9. Coffer PJ, Jin J, Woodgett JR. 1998. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335:1-13.
10. Cox LS. 1997. Multiple pathways control cell growth and transformation: Overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J Pathol 183:134-140.
11. Dietz AB, Vuk-Pavlovic S. 1998. High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 91:392-398.
12. Dubourdeau M, Miyamura T, Matsuura Y, Alric L, Pipy B, Rousseau D. 2002. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation-effect of transforming growth factor beta. J Hepatol 37:486-492.
13. 2/M-phase transition. Mol Cell Biol 18:546-557.
14. 1 arrest and apoptosis. Cancer Res 54:1169-1174.
15. Everett H, McFadden G. 1999. Apoptosis: An innate immune response to virus infection. Trends Microbiol 7:160-165.
16. Fujio Y, Quo K, Mano T, Mitsuuchi Y, Testa JR, Walsh K. 1999. Cell cycle withdrawal promotes myogenic induction of Akt: A positive modulator of myocyte survival. Mol Cell Biol 19:5073-5082.
17. Ghosh AK, Steele R, Meyer K, Ray R, Ray RB. 1999. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 80:1179-1183.
18. Ghosh AK, Majumder M, Steele R, Meyer K, Ray R, Ray RB. 2000. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res 67:173-178.
19. Gorospe M, Holbrook NJ. 1996. Role of p21 in prostaglandin A2-mediated cellular arrest and death. Cancer Res 56:475-479.
20. Han HJ, Jung EY, Lee WJ, Jang KL. 2002. Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett 518:169-172.
21. 1 cyclin-dependent kinases. Cell 75:805-816.
22. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N. 1995. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6:387-400.
23. Hemmings BA. 1997. Akt signaling: Linking membrane events to life and death decisions. Science 275:628-630.
24. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 88:5547-5551.
25. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 67:4665-4675.
26. Honda M, Kaneko S, Shimazaki T, Matsushita E, Kobayashi K, Ping LH, Zhang HC, Lemon SM. 2000. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 31:1351-1359.
27. Jung EY, Lee MN, Yang HY, Yu D, Jang KL. 2001. The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation. Virus Res 79:109-115.
28. Kakumu S, Ito S, Ishikawa T, Mita Y, Tagaya T, Fukuzawa Y, Yoshioka K. 2000. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol 15:431-436.
29. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162:5584-5591.
30. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag J, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton H. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
31. Kwong AD, Kim JL, Lin C. Structure and function of hepatitis C virus NS3 helicase. 2000. Curr Top Microbiol Immunol 242:171-196.
32. Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL. 2001. p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. J Gen Virol 82:2235-2241.
33. Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD. 2002. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21:4801-4811.
34. Lee MN, Jung EY, Kwun HJ, Jun HK, Yu DY, Choi YH, Jang KL. 2002. Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway. J Gen Virol 83:2145-2151.
35. Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A, Mehtali M. 1998. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol 72:2022-2032.
36. Majumder M, Ghosh AK, Steele R, Ray R, Ray RB. 2001. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75:1401-1407.
37. Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB. 2002. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology 294:94-105.
38. McLauchlan J. 2000. Properties of the hepatitis C virus core protein: A structural protein that modulates cellular processes. J Viral Hepat 7:2-14.
39. Mizushima H, Hijikata M, Asabe S, Hirota M, Kimura K, Shimotohno K. 1994. Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol 68:6215-6222.
40. Navas MC, Fuchs A, Schvoerer E, Bohbot A, Aubertin AM, Stoll-Keller F. 2002. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection. J Med Virol 67:152-161.
41. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL, Ross AH. 1996. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16:1335-1341.
42. Qadri I, Iwahashi M, Simon F. 2002. Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592:193-204.
43. Ray RB, Steele R, Meyer K, Ray R. 1997. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272:10983-10986.
44. Ray RB, Steele R, Meyer K, Ray R. 1998. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208:331-336.
45. Reich NC, Sarnow P, Duprey E, Levine AJ. 1983. Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology 128:480-484.
46. Reyes GR. 2002. The nonstructural NS5A protein of hepatitis C virus: An expanding, multifunctional role in enhancing hepatitis C virus pathogenesis. J Biomed Sci 9:187-197.
47. Ruggieri A, Harada T, Matsuura Y, Miyamura T. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68-76.
48. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118.
49. Sarobe P, Lasarte JJ, Casares N, Lopez-Diaz de Cerio A, Baixeras E, Labarga P, Garcia N, Borras-Cuesta F, Prieto J. 2002. Abnormal priming of CD4 (+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 76:5062-5070.
50. Sarobe P, Lasarte JJ, Zabaleta A, Arribillaga L, Anna A, Melero I, Borras-Cuesta F, Prieto J. 2003. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol 77:10862-10871.
51. Serrano M, Hannon GJ, Beach D. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
52. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493-504.
53. Sheikh MS, Garcia M, Zhan Q, Liu Y, Fornace AJ, Jr. 1996. Cell cycle-independent regulation of p21Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. Cell Growth Differ 7:1599-1607.
54. Sherr CJ. 1993. Mammalian G1 cyclins. Cell 73:1059-1065.
55. Siavoshian S, Abraham JD, Kieny MP, Schuster C. 2004. HCV core, NS3, NS5A, and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Arch Viroll 49:323-336.
56. Somasundaram K. 2000. Tumor suppressor p53: Regulation and function. Front Biosci 5:424-437.
57. Tanji Y, Hijikata M, Satoh S, Kaneko T, Shimotohno K. 1995. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 69:1575-1581.
58. Thoren F, Romero A, Lindh M, Dahlgren C, Hellstrand K. 2004. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: Role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 76:1180-1186.
59. Tomei L, Failla C, Santolini E, De Francesco R, La Monica N. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67:4017-4026.
60. Wang J, Walsh K. 1996. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359-361.
61. Watson RW. 1999. The rising incidence of hepatocellular carcinoma. N Engl J Med 341:451-452.
62. Wiman KG. 1997. p53: Emergency brake and target for cancer therapy. Exp Cell Res 237:14-18.
63. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
64. Yoshida I, Oka K, Hidajat R, Nagano-Fujii M, Ishido S, Hotta H. 2001. Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein. Microbiol Immunol 45:689-697.
65. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MM. 1998. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72:3691-3697.